Ying Tao, MD
Neurology · Elizabeth, NJNPI 1265402812
Payments from drug & device makers
Across 134 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$464
- AstraZeneca$189
- Biogen$182
- Neurocrine Biosciences, Inc.$179
- UCB, Inc.$143
- Scilex Pharmaceuticals Inc.$108
- plus $652 from 20 others
What the payments were for
- Food & beverage$1,917100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $464 |
| AstraZeneca(2 entities) | 13 | $189 |
| Biogen | 12 | $182 |
| Neurocrine Biosciences, Inc. | 11 | $179 |
| UCB, Inc. | 10 | $143 |
| Scilex Pharmaceuticals Inc. | 6 | $108 |
| Lilly USA, LLC | 7 | $97 |
| Eisai Inc. | 5 | $69 |
| Sunovion Pharmaceuticals Inc. | 5 | $62 |
| SK Life Science, Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Genentech USA, Inc. | 2 | $33 |
| Aucta Pharmaceuticals, Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| EMD Serono, Inc. | 2 | $29 |
| Strongbridge US Inc. | 2 | $28 |
| GE HealthCare | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Aprecia Pharmaceuticals, LLC | 2 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Amgen | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Novartis | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Grifols USA, LLC | 1 | $11 |
How this compares
$1,917 in reported general payments places this provider in the 50th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tegretol XrCarbamazepine | 11 | $13,522 |
| Levetiracetam | 299 | $5,881 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 130 | $4,718 |
| Memantine Hcl | 208 | $4,553 |
| Gabapentin | 271 | $3,434 |
| Lacosamide | 37 | $3,422 |
| Divalproex Sodium | 38 | $3,258 |
| Rivastigmine | 13 | $2,836 |
| Carbamazepine ErCarbamazepine | 27 | $2,554 |
| Divalproex Sodium ErDivalproex Sodium | 70 | $1,794 |
| Donepezil Hcl | 291 | $1,771 |
| Oxcarbazepine | 22 | $1,660 |
| Nortriptyline Hcl | 164 | $1,466 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 102 | $1,425 |
| Primidone | 163 | $1,425 |
Paid to pharmacies, not to this prescriber.
Other neurology in Elizabeth
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.